Delivery Order SPE2DR25D9127-SPE2DR26FDAC5
Award Date 5/12/26
Potential Completion Date 6/3/26
Potential Value $20K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $19,759.23 delivery order to DMS Pharmaceutical Group Inc. on May 7, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for Firdapse 10 mg tablets. Ultimate completion date is May 29, 2026. PPV-G GEN V is a single-award indefinite delivery contract with a $499.999 billion ceiling supporting pharmaceutical and medical consumable supply to Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical...
- The Defense Logistics Agency issued a $19,759.23 delivery order to DMS Pharmaceutical Group Inc. on April 3, 2026, for Firdapse 10 mg tablets under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract with a $499.9 billion ceiling authorizing firm fixed-price delivery orders for pharmaceutical products, biologics, and medical consumables to support Department of Defense healthcare operations globally....
- The Defense Logistics Agency issued a $11,844.88 delivery order to DMS Pharmaceutical Group Inc. on March 20, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products to support Department of Defense medical supply needs. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract with a $499.9 billion ceiling authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications,...
- The Defense Logistics Agency issued a $24,132.70 delivery order to DMS Pharmaceutical Group Inc. on May 11, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply to defense medical facilities. PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling running through December 31, 2036. DMS Pharmaceutical is the sole regional prime vendor authorized to issue firm fixed-price delivery...
- The Defense Logistics Agency issued a $17,545.72 delivery order to DMS Pharmaceutical Group Inc. on January 13, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products. PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract with a $499.9 billion ceiling supporting pharmaceutical distribution to Department of Defense healthcare facilities worldwide. The order is firm fixed price with an ultimate completion date...
- The Defense Logistics Agency issued a $3,863.68 delivery order to DMS Pharmaceutical Group Inc. on March 17, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract for pharmaceutical products. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to military healthcare facilities worldwide, with a ceiling value of $499.999 billion and ultimate completion date of December 31, 2036. DMS...
- The Defense Logistics Agency issued a $14,195.52 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on May 6, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply. PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling supporting Department of Defense pharmaceutical distribution worldwide. DMS Pharmaceutical serves as the sole regional prime vendor...
- The Defense Logistics Agency issued a $17,866.52 delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products to support Department of Defense healthcare operations. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract with a $499,999,999 ceiling and a December 31, 2036 ultimate completion date. DMS Pharmaceutical Group is a woman-owned small business...
- The Defense Logistics Agency issued a $1,774.84 delivery order to DMS Pharmaceutical Group Inc. on May 12, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply to military healthcare facilities. DMS Pharmaceutical Group Inc. is a woman-owned small business. PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract framework with a $499.999 billion ceiling and ultimate completion date of December 31, 2036,...
- The Defense Logistics Agency issued a $19,332.22 delivery order to DMS Pharmaceutical Group Inc. on April 24, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply to Department of Defense military healthcare facilities. PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling and ultimate completion date of December 31, 2036. DMS Pharmaceutical is the sole regional prime vendor...